| CTRI Number |
CTRI/2021/11/038268 [Registered on: 25/11/2021] Trial Registered Prospectively |
| Last Modified On: |
07/12/2021 |
| Post Graduate Thesis |
No |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
To compare the results of two treatment protocol (standard treatment plus vitamin c, thiamine and hydrocortisone versus standard treatment plus hydrocortisone) used in surgical patients with septic shock (a/k/a infection in the body presenting with low blood pressure). |
|
Scientific Title of Study
|
Metabolic resuscitation using early administration of ascorbic acid, thiamine and hydrocortisone in perioperative management of surgical patients with septic shock: A Randomized Controlled trial |
| Trial Acronym |
|
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Manjunath Maruti Pol |
| Designation |
Additional Professor Surgery |
| Affiliation |
All India Institute of Medical Sciences New Delhi |
| Address |
Department of Surgical Disciplines, CMET, All
India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi Department of Surgical Disciplines, CMET, All
India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi South DELHI 110029 India |
| Phone |
09990187137 |
| Fax |
|
| Email |
manjunath.pol@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Manjunath Maruti Pol |
| Designation |
Additional Professor Surgery |
| Affiliation |
All India Institute of Medical Sciences New Delhi |
| Address |
Department of Surgical Disciplines, CMET, All
India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi Department of Surgical Disciplines, CMET, All
India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi South DELHI 110029 India |
| Phone |
09990187137 |
| Fax |
|
| Email |
manjunath.pol@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Manjunath Maruti Pol |
| Designation |
Additional Professor Surgery |
| Affiliation |
All India Institute of Medical Sciences New Delhi |
| Address |
Department of Surgical Disciplines, CMET, All
India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi Department of Surgical Disciplines, CMET, All
India Institute of Medical Sciences (AIIMS), Ansari Nagar, New Delhi South DELHI 110029 India |
| Phone |
09990187137 |
| Fax |
|
| Email |
manjunath.pol@gmail.com |
|
|
Source of Monetary or Material Support
|
|
|
Primary Sponsor
|
| Name |
AIIMS NEW DELHI |
| Address |
Department of Surgical Disciplines. CMET, Second floor teachingblock
AIIMS main building. All India Institute of Medical SciencesAIIMS Ansari
Nagar New Delhi South DELHI |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Manjunath Maruti Pol |
AIIMS Delhi |
Department of Surgical Disciplines CMET teaching block AIIMS main building All India Institute of Medical Sciences AIIMS Ansari Nagar New Delhi South DELHI South DELHI |
09990187137
manjunath.pol@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| AIIMS Institute Ethics Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: A419||Sepsis, unspecified organism, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Group A |
Standard treatment
plus
Hydrocortisone 100 mg IV bolus then 50 mg IV every 6th hourly for 10 days
Ascorbic acid 1.5 gm. q 6th hourly for 10 days
Thiamine 200Â mg q 12th hourly for 10 days
|
| Comparator Agent |
Group B |
Standard treatment
plus
Hydrocortisone 100 mg IV bolus then 50 mg IV every 6th hourly for 10 days
|
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
70.00 Year(s) |
| Gender |
Both |
| Details |
1. Perioperative septic shock: peritonitis due to hollow viscus perforation, ruptured solid organ abscess, pyoperitoneum, intestinal obstruction.
2. Controlled source of infection: Post-intervention (surgical or non-surgical) control of source of infection
3. 18 to 70 years, both gender
4. Ready to participate in the study
|
|
| ExclusionCriteria |
| Details |
1. Age < 18 years and > 70 years
2. Refusal to consent and DNR orders (patient or patients family do not consent for the resuscitation and study)
3. Septic shock for > 24 hours
4. Failure to administer intervention drugs within 6 hours of presentation of septic shock
5. Proven active COVID-19 infection, HIV infection, known immunodeficiency diseases
6. Allergy to either of the intervention drugs (allergy to ascorbic acid or thiamine or hydrocortisone)
7. Uncontrollable source of infection e.g., Unresectable dead bowel,
8. Recurrent, unresectable or metastatic cancer
9. Patient on antifungal infection for systemic fungal infection
10. Imminent death or Inevitable deaths: metastatic cancer or haematological malignancy, more than four failed organs at entry (or multiorgan dysfunction syndrome), APACHE II score > 30 at presentation, granulocytopenia leucocyte count < 500cells/ml and/or thrombocytopenia< 30000 cells/ml)
11. Alternate diagnosis causing shock e.g., myocardial infarction and severe congestive cardiac failure (NYHA class IV), pulmonary embolism, Child Pugh class C liver disease, patients on immunosuppressant’s, chemotherapy / radiotherapy within 30 days prior to sepsis, haemorrhagic shock or GCS-3.
12. Pregnancy or breastfeeding
13. G6PD deficiency
14. Patients already on hydrocortisone, ascorbic acid and thiamine for reasons other than septic shock
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Open Label |
|
Primary Outcome
|
| Outcome |
TimePoints |
| 1. Inotrope free survival (Cessation of vasopressor) |
Hours to 10 days |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1. Reduction in Sequential Organ Failure Assessment (SOFA) Score
2. Duration of hospital stay
3. Duration of ICU stay
4. Mortality
|
1. 0 to 24
2. 1 to 30 days
3. 1 to 30 days
4. 1 to 30 days |
|
|
Target Sample Size
|
Total Sample Size="60" Sample Size from India="60"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
29/11/2021 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Open to Recruitment |
|
Publication Details
|
NIL |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Background and rationale of the study: · Sepsis is a life threatening clinical syndrome caused by dysregulated host immune response to infection leading to constellation of physiologic and biochemical abnormalities. Thus, sepsis involves persistent inflammation, immunosuppression and catabolic syndrome. · Our observation suggests that there was > 50% mortality witnessed during perioperative management of surgical patients with septic shock. As there is no study comparing the two treatment protocols in perioperative management of surgical patients with septic shock, an intervention to look for the difference and enhance the outcome in surgical patients with septic shock is warranted. · From the available literature, there have been no reports of suspected, unexpected, or serious adverse reactions to dose and frequency of intervention drugs to be used in this study. · The role of cocktail of Vit-C and hydrocortisone is under investigation. It has been used in cases of medical sepsis. · Hypothesis behind use of Vit-C and thiamine in septic shock: The concept that inotrope induced vasoconstriction and lactic acidosis has come under criticism. It is postulated that tissue hypoxia is not the actual cause for excess production of lactic acid, but when excess amount of pyruvate is generated it gets bypassed (from Krebs cycle) to form lactic acid due to lack of vitamins. Secondly, due to infection the receptor (SVCT2) needed for transport of Vit- C is decreased, and the corticosteroids receptor is oxidized by the inflammatory mediators. Therefore, it is observed that giving hydrocortisone increases expression of SVCT2, and Vit-C helps to reverse oxidized corticosteroids receptors. · There is no study in the English literature comparing the two treatment protocol [standard treatment plus cocktail of vitamin and hydrocortisone versus standard treatment plus hydrocortisone] in patients with surgical sepsis. However, there are a few articles published in medical journals (Marik PE et al. Chest. 2017 and Fujii T et. Al JAMA. 2020) that involved majority of patients with pulmonary sepsis. [1, 2] In a study published by Marik PE et al. Chest. 2017 it was observed that early administrations of higher doses of vitamin-c and thiamine along with corticosteroids in pulmonary sepsis prevented progression of disease and reduced mortality. On contrary, the vitamins trial (Fujii T et. Al JAMA. 2020) did not reflect similar results that could be due to non-adherence to sepsis protocol. Variations in their outcome could have resulted because of differences in their study design and execution. Hence, there is an on-going debate about role of metabolic resuscitation in medical sepsis.
1. 1. Marik PE, Khangoora V, Rivera R, et al. Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Severe Sepsis and Septic Shock: A Retrospective Before-After Study. Chest. 2017; 151(6): 1229-1238. 2. 2.Fujii T, Luethi N, Young PJ, et al. Effect of Vitamin C, Hydrocortisone, and Thiamine vs Hydrocortisone Alone on Time Alive and Free of Vasopressor Support Among Patients With Septic Shock: The VITAMINS Randomized Clinical Trial. JAMA. 2020; 323(5): 423-431. |